Atrial Fibrillation Following Autologous Stem Cell Transplantation in Multiple Myeloma
AF is a frequent and high-risk complication among MM patients undergoing ASCT. Routinely available clinical factors enable risk stratification, underscoring the importance of cardiovascular evaluation and vigilant post-transplantation monitoring in this vulnerable population.
Authors
- Brian C. Shaffer (ORCID: https://orcid.org/0000-0003-3433-9179)
- G. L. Shah
- Glenn Heller
- Michael Scordo
- Carol L. Chen
- Anthony F. Yu
- James E. Ip
- Sergio Giralt
- Roni Shouval
- Samantha Brown
- Ioanna Kosmidou
- Olayiwola Bolaji
- Marie-Claude Beaulieu
- Jennifer E. Liu
- Heather J. Landau
- Usmani Saad
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Cornell University (US)
- Weill Cornell Medicine (US)
Publication Details
- Journal
- JACC CardioOncology
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1016/j.jaccao.2025.12.008
- Citations
- 1
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 35.41